KLF13 Loss-Of-Function Variation Contributes to Familial Congenital Heart Defects
Total Page:16
File Type:pdf, Size:1020Kb
European Review for Medical and Pharmacological Sciences 2020; 24: 11273-11285 KLF13 loss-of-function variation contributes to familial congenital heart defects S.-S. WANG1, T.-M. WANG1, X.-H. QIAO2, R.-T. HUANG3, S. XUE3, B.-B. DONG4, Y.-J. XU5,6, X.-Y. LIU1, Y.-Q. YANG5-7 1Department of Pediatrics, Tongji Hospital, Tongji University School of Medicine, Shanghai, China 2Department of Pediatric Internal Medicine, Ningbo Women & Children’s Hospital, Ningbo, China 3Department of Cardiovascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China 4Department of Pediatrics, Huashan Hospital North, Fudan University, Shanghai, China 5Department of Cardiology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China 6Cardiovascular Research Laboratory, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China 7Central Laboratory, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China Shan-Shan Wang, Tian-Ming Wang and Xiao-Hui Qiao contributed equally to the work Abstract. – OBJECTIVE: Congenital heart de- two other genes that have been recognized to fect (CHD) represents the most common form cause CHD. of human developmental abnormality and con- CONCLUSIONS: These findings firstly indicate tributes to substantial morbidity, mortality, and that genetically defective KLF13 predisposes to socioeconomic burden worldwide. Accumulat- familial CHD, implying potential implications for ing evidence underscores the strong genetic ba- genetic counseling and an improved prophylac- sis of CHD. Nevertheless, CHD is of pronounced tic strategy in a subset of CHD patients. genetic heterogeneity, and the genetic determi- nants underlying CHD in most patients are still Key Words: unclear. This study was mainly sought to identi- Congenital heart disease, Molecular genetics, Tran- fy the causative gene for CHD in a consanguine- scriptional factor, KLF13, Reporter gene assay. ous Chinese family. PATIENTS AND METHODS: Whole-exosome sequencing and bioinformatics analyses were performed in a Chinese family with CHD (dou- Introduction ble-outlet right ventricle and ventricular septal defect), which was transmitted in an autosomal dominant pattern. A total of 312 unrelated healthy Congenital heart defect (CHD), which usually individuals were then genotyped for the identi- refers to any structural malformation of the heart fied genetic variation. The functional effect of the or endothoracic great blood vessels arising before identified variation was characterized by utilizing birth, is the most common birth defect in humans a Dual-Luciferase reporter assay system. with an estimated 1% prevalence in live births1. If RESULTS: A novel heterozygous variation, minor cardiac anomalies, such as bicuspid aortic NM_015995.3: c.370G>T; p.(Glu124*), was iden- valve are included, the total prevalence of CHD is tified in the KLF13 gene, which encodes Krup- 1 pel-like factor 13 key to proper heart develop- up to 2% to 3% . Although minor CHD can resolve ment. Genetic analysis of the pedigree unveiled spontaneously2, major CHD may result in degraded that the variation co-segregated with CHD, with health-related quality of life3-6, decreased exercise complete penetrance. The variation was absent performance7-10, retarded nervous system develop- from 624 control chromosomes. The biological ment and brain injury11-14, ischemic or hemorrhagic analysis revealed that the Glu124*-mutant KLF13 cerebral stroke15-17, pulmonary arterial hypertension protein failed to transactivate its cardiac target 18-20 genes ACTC1 and ANP. Furthermore, the vari- or Eisenmenger syndrome , infective endocardi- 21-23 24-28 ation disrupted the synergistic transactivation tis , myocardial dysfunction or heart failure , between KLF13 and GATA4, as well as GATA6, ventricular or supraventricular arrhythmias29-31, Corresponding Authors: Xing-Yuan Liu, MD; e-mail: [email protected] Yi-Qing Yang, MD; e-mail: [email protected] 11273 S.-S. Wang, T.-M. Wang, X.-H. Qiao, R.-T. Huang, S. Xue, B.-B. Dong, Y.-J. Xu, X.-Y. Liu, Y.-Q. Yang and cardiac demise32-34. Actually, CHD remains the somal dominant trait was enrolled. Additionally, most common etiology of infant death resulted from 236 index patients suffering from CHD were also birth defects, with approximately 24% of neonates included. The control individuals comprised 312 who died of a birth defect having CHD2. Although unrelated individuals with no heart disease. The tremendous advance in cardiac surgery and cathe- CHD patients were matched with the healthy con- ter-based intervention, as well as perioperative in- trol subjects for ethnicity, sex, and age. Each study tensive care, has dramatically improved survival, al- participant underwent a comprehensive clinical lowing more than 90% of CHD neonates to survive evaluation, including a thorough review of fa- into adulthood, it leads to a growing body of adult milial, personal and medical histories, a detailed population with CHD, and adults with CHD have physical examination, echocardiogram, electro- outnumbered children with CHD2,35. Moreover, the cardiogram, and routine biochemical tests. Di- late complications and even sudden cardiac death agnosis of CHD was made by echocardiography, significantly increase in adult survivors living with cardiac catheterization and/or cardiac surgery. Pa- CHD36-38. Hence, CHD has conferred a substantially tients with known chromosomal abnormalities or increased socioeconomic burden39-41. Despite im- syndromic CHD were ruled out from the current portant clinical significance, the molecular etiolo- investigation. The investigation was carried out in gies of CHD remain largely obscure. conformity with the ethical principles outlined in In vertebrates, the heart is the first functional or- the Declaration of Helsinki. The protocol used in gan that develops during embryogenesis, and cardi- this investigation was reviewed and approved by ac morphogenesis is a complex biological process, the Medical Ethics Committee of Tongji Hospital, which is finely controlled by a modulatory network, Tongji University School of Medicine, Shanghai, encompassing transcription factors, signaling mole- China [Ethical Approval Number: LL(H)-09-07]. cules, and epigenetic modifiers42. Previous research- Prior to the commencement of the investigation, es42-46 have demonstrated that both environmental written informed consent was given by the study and genetic pathogenic factors may interrupt this bi- participants or their legal guardians. Subsequent- ological process, giving rise to CHD. The nongenetic ly, a peripheral venous blood sample (about 2 mL) environmental risk factors for CHD include maternal was collected from each study subject. Genom- conditions (such as viral infection, metabolic disor- ic DNA was extracted from venous blood leu- der, and lack of nutrition) and exposures to toxicants, cocytes with the FlexiGene DNA Kit (Qiagen, therapeutic chemicals, and ionizing radiation during Hilden, Germany), then, stored at −80°C. the first trimester of pregnancy45,46. However, accu- mulating investigations highlight the strong genet- Genetic Analyses ic basis for CHD, and in addition to chromosomal For each sample, a whole exome library was deletions and duplications, an increasing number of constructed with 3 mg of genomic DNA by ran- variations in over 100 genes, including those coding dom fragmentation using an ultrasonicator (Co- for cardiac transcription factors, cellular signaling varis, Woburn, MA, USA), and captured using molecules, and myocardial structural proteins, have the SureSelectXT Human All Exon V6 Kit (Ag- been found to cause CHD in humans42-44,47-69. Among ilent Technologies, Santa Clara, CA, USA), fol- these well-established CHD-causing genes, most en- lowing the manufacturer’s instructions. Enriched code cardiac core transcription factors, encompass- exome libraries were sequenced with the HiSeq ing GATA4, TBX20, GATA6, NKX2-5, GATA5, Sequencing Kit (Illumina, San Diego, CA, USA) HAND1, and HAND270. Nevertheless, the genetic on an Illumina HiSeq 2000 Genome Analyzer (Il- determinants underpinning CHD in the vast majority lumina) according to the manufacturer’s protocol. of cases remain unknown. The current investigation Exome sequences were mapped to the human ref- was sought to identify a novel gene responsible for erence genome sequence (hg19, GRCh37) using CHD and reveal the underlying mechanism by which the BWA software. The resulting SAM files were the genetic variation contributes to CHD. converted to the BAM files using SAMtools, and duplicates were removed with the Picard software. The GATK software package was applied to base Subjects and Methods quality score recalibration, local realignment, and variant calls. The called variants that passed the Study Subjects pedigree analysis were annotated by virtue of the In this investigation, a three-generation Chi- software ANNOVAR. The candidate variants nese family with CHD transmitted as an auto- identified by whole exome sequencing (WES) 11274 KLF13 variation contributes to congenital heart defects Table I. Primers for amplification of the coding exons and splicing donors/acceptors of the KLF13 gene. Coding exon Forward primer (5´→3´) Backward primer (5´→3´) Amplicon (bp) 1-a CCATGCGCTCACTCTTCGGT CCTTTGTCTGAGGCCGGGCT 670 1-b CGGACCTCAACCAGCAAGCG CTCCGAGAGCCAAGACCCGC 569 2 GCATGTGGGAGGGGTGTTGA TCGTGAAACGTGTCCATCCCT 675 and bioinformatics analyses of the CHD family sis Kit (Stratagene, San Diego, CA, USA) with a were further